Precision BioSciences, Inc. (DTIL)
9.87
+1.75
(+21.55%)
USD |
NASDAQ |
Nov 05, 16:00
9.80
-0.07
(-0.71%)
After-Hours: 07:29
Precision BioSciences Market Cap : 275.30M for Nov. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 275.30M |
| November 04, 2026 | 226.49M |
| November 03, 2026 | 194.41M |
| November 02, 2026 | 193.86M |
| October 30, 2026 | 196.93M |
| October 29, 2026 | 207.52M |
| October 28, 2026 | 197.46M |
| October 27, 2026 | 179.48M |
| October 26, 2026 | 169.44M |
| October 23, 2026 | 175.52M |
| October 22, 2026 | 179.22M |
| October 21, 2026 | 177.37M |
| October 20, 2026 | 173.40M |
| October 19, 2026 | 163.62M |
| October 16, 2026 | 152.52M |
| October 15, 2026 | 163.10M |
| October 14, 2026 | 159.39M |
| October 13, 2026 | 161.24M |
| October 12, 2026 | 172.61M |
| October 09, 2026 | 177.63M |
| October 08, 2026 | 169.97M |
| October 07, 2026 | 165.21M |
| October 06, 2026 | 163.89M |
| October 05, 2026 | 166.80M |
| October 02, 2026 | 166.80M |
| Date | Value |
|---|---|
| October 01, 2026 | 167.32M |
| September 30, 2026 | 165.47M |
| September 29, 2026 | 163.36M |
| September 28, 2026 | 164.95M |
| September 25, 2026 | 164.42M |
| September 24, 2026 | 167.32M |
| September 23, 2026 | 168.12M |
| September 22, 2026 | 190.06M |
| September 21, 2026 | 171.82M |
| September 18, 2026 | 176.31M |
| September 17, 2026 | 176.31M |
| September 16, 2026 | 175.25M |
| September 15, 2026 | 174.73M |
| September 14, 2026 | 181.33M |
| September 11, 2026 | 189.53M |
| September 10, 2026 | 191.38M |
| September 09, 2026 | 191.64M |
| September 08, 2026 | 195.61M |
| September 04, 2026 | 197.46M |
| September 03, 2026 | 194.82M |
| September 02, 2026 | 196.93M |
| September 01, 2026 | 201.95M |
| August 31, 2026 | 201.95M |
| August 28, 2026 | 205.65M |
| August 27, 2026 | 222.04M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 274.44M |
| Amgen, Inc. | 249.01B |
| Anika Therapeutics, Inc. | 258.69M |
| BioCryst Pharmaceuticals, Inc. | 1.948B |
| Imunon, Inc. | 4.200M |
Market Cap Related Metrics
| PS Ratio | 5.319 |
| Price to Book Value | 5.317 |
| Price | 9.87 |
| Earnings Yield | -13.01% |